What is Keeps?
Keeps operates at the intersection of technology and personal healthcare, providing a streamlined platform for men seeking FDA-approved treatments for hair loss. By offering a direct-to-consumer model, the company simplifies the process of obtaining medications such as Finasteride and Minoxidil, which are essential for managing male pattern baldness. The platform integrates expert-led treatment plans with ongoing support from licensed medical providers, effectively removing traditional barriers to entry in the healthcare market.
Beyond its core hair loss offerings, Keeps has expanded its scope to include sexual health services, positioning itself as a comprehensive digital health destination. Its focus on affordability, convenience, and clinical oversight has allowed it to capture significant market share, challenging legacy pharmacy models and establishing a new standard for patient-centric care in the digital age.
How much funding has Keeps raised?
Keeps has raised a total of $15.3M across 2 funding rounds:
Series A
$15.3M
Debt
$31K
Series A (2018): $15.3M with participation from ERA, Two River, Maveron, Greycroft Partners, First Round Capital, Steadfast Venture Capital, HillCour, and Northzone
Debt (2021): $31K led by PPP
Key Investors in Keeps
Maveron
Maveron is a consumer-only venture capital firm that partners with innovative entrepreneurs to transform consumer experiences and industries, focusing on early-stage brands that prioritize human behavior.
Greycroft Partners
Greycroft is a leading venture capital firm focused on investments in the Internet and mobile markets, leveraging an extensive network to help entrepreneurs build successful, scalable businesses.
Northzone
Northzone is a multi-stage venture capital fund with over $1.7 billion under management, known for backing category-defining businesses across multiple economic and technology cycles.
What's next for Keeps?
With the recent influx of $31K, Keeps is well-positioned to deepen its market penetration and enhance its service delivery capabilities. The company is expected to prioritize the optimization of its supply chain and the expansion of its clinical network, ensuring that it can maintain high standards of care while scaling its user acquisition efforts. Furthermore, the strategic use of this capital will likely support the development of new product lines and the integration of advanced digital health tools to improve patient outcomes.
As the telehealth industry continues to mature, Keeps remains focused on long-term sustainability and brand loyalty. By maintaining its commitment to evidence-based treatments and user-friendly technology, the company is poised to navigate the complexities of the healthcare sector, potentially exploring further diversification of its wellness portfolio to address broader consumer health needs.
